Status:

COMPLETED

Regular Home Use of Dual-light Photodynamic Therapy in the Management of Chronic Periodontitis

Lead Sponsor:

Koite Health Oy

Collaborating Sponsors:

University of Helsinki

Conditions:

Periodontitis

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The study is a single site, randomized clinical trial designed to determine the efficacy of the Lumoral treatment in periodontitis patients.

Detailed Description

Lumoral treatment is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial pho...

Eligibility Criteria

Inclusion

  • Periodontal disease stage I-III, according to criteria the American Academy of Periodontology (AAP) with at least 2 mm interdental CAL in the site of greatest loss
  • Age of 18-85 years
  • Presence of \> 20 teeth
  • Agreement to participate in the study and to sign a written consent form

Exclusion

  • Untreated/uncontrollable diabetes mellitus (DM) with HbA1c \>7%, and HbA1c \> 8 if insulin treated DM
  • Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of periodontal disease
  • Use of medicine that would affect the periodontal tissue within the last 6 months (antibiotics, anti-inflammatories, anticonvulsants, immunosuppressants, or calcium channel blockers, including doxycycline, bisphosphonates and chlorhexidine)
  • Periodontal treatment during the previous 3 months
  • Allergic to the photosensitizer
  • Presence of major physical limitation or restriction that prohibit the hygiene procedures used in the study protocol
  • Removable major prosthesis or major orthodontic appliance
  • Active smoking, or habitual use of smokeless tobacco products
  • Pregnancy or lactation
  • A need for a hopeless teeth extraction, or open cavities in need for immediate endodontic treatment

Key Trial Info

Start Date :

February 8 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 29 2025

Estimated Enrollment :

202 Patients enrolled

Trial Details

Trial ID

NCT05278416

Start Date

February 8 2022

End Date

April 29 2025

Last Update

August 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Metropolia University of applied sciences

Helsinki, Finland